Lukoon

GCC Diabetic Retinopathy Market Size, Share, and Forecast Analysis to 2035

2 min read
0
Comments
44
Views

Managing diabetic retinopathy in the Gulf Cooperation Council (GCC) relies on a combination of pharmacotherapy, laser surgeries, and advanced vitreoretinal surgical techniques. Insights from the GCC Diabetic Retinopathy Market Analysis demonstrate a significant shift away from traditional focal laser photocoagulation toward targeted biologic therapies, particularly anti-Vascular Endothelial Growth Factor (anti-VEGF) agents and sustained-release corticosteroid implants.

Dominance of Anti-VEGF Pharmacotherapy

Anti-VEGF intravitreal injections have established themselves as the standard of care for center-involved diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR). Key drug therapies regularly administered across GCC tertiary care hospitals include:

  • Ranibizumab and Aflibercept: Widely favored for their proven clinical efficacy in improving visual acuity and reducing central retinal thickness.

  • Biosimilars and Novel Molecules: Emerging low-cost alternatives and longer-acting agents that aim to extend dosing intervals and alleviate patient treatment burdens.

The high frequency of required clinic visits for anti-VEGF injections is driving clinical preference toward longer-acting formulations that maintain intraocular drug concentrations over extended periods.

Intravitreal Steroid Implants and Laser Photocoagulation

For patients exhibiting insufficient responses to anti-VEGF therapies or those with chronic DME, sustained-release corticosteroid implants (such as dexamethasone and fluocinolone acetonide inserts) offer an effective second-line therapeutic option. Concurrently, pan-retinal photocoagulation (PRP) laser therapy continues to be utilized to regress abnormal retinal neovascularization, often combined with pharmacotherapy to deliver optimized long-term clinical outcomes.

Vitreoretinal Surgical Interventions

In advanced cases characterized by persistent vitreous hemorrhage, tractional retinal detachment, or dense fibrovascular membranes, vitreoretinal surgery (vitrectomy) becomes imperative. Advanced eye hospitals across Dubai, Riyadh, and Doha are equipped with modern micro-incisional vitrectomy systems (MIVS), enabling specialized surgeons to restore visual function with reduced recovery times and minimal surgical complications.

Strengthen your strategy with data-backed research insights:

Hypercholesterolemia Treatment Market Outlook

Acquired Methemoglobinemia Market Analysis

Syphilis Testing Market Distribution

Pulse Field Ablation System Market Size

US Plasma Fractionation Market Share